Remote Evaluation of MIND Diet
The goal of this clinical trial is to learn if increasing adherence to a Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet pattern improves thinking ability and memory compared to a healthy control diet in persons with Multiple Sclerosis (MS). The main question it aims to answer is: Does the MIND diet improve cognitive performance relative to a control diet in persons with MS? Participants will: Consume one meal that follows the MIND diet or a control meal every day for 3 months, complete online surveys and cognitive testing before and after, and keep a record of the food they eat during the study.
• Individuals aged 18-64 years old
• Self-reported diagnosis of Multiple sclerosis (MS)
• 20/20 or corrected vision
• No other neurodegenerative disease diagnosis
• Stable disease-modifying therapy (DMT) within 6 months
• Not Pregnant or lactating
• No food allergies or intolerances
• Able to consume study meals
• Not enrolled in another dietary, exercise, or medication study during the study
⁃ Access to a computer/laptop with internet